稳定性付出代价:在生物吸收性与金属综合性固定中评估术后并发症:系统性审查
Andy Suarez1, Leon Liu1, Taylor Checkley1
1Health Professions Division, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, USA.
Cureus
|March 9, 2026
概括
脚骨折的生物吸收螺丝显示出比金属螺丝更高的并发症率,包括感染和修复手术. 由于对生物吸收选项的安全性担忧,金属螺丝在综合性固定方面仍然更可靠.
科学领域:
- 整形外科手术 整形外科手术
- 生物材料科学 生物材料科学
- 创伤管理 创伤管理
背景情况:
- 可生物吸收的螺丝越来越多地用于脚骨折的综合性固定,以避免二次切除手术.
- 与传统的金属螺丝相比,生物吸收螺丝的安全性和有效性仍然存在担忧,特别是在并发症率方面.
研究的目的:
- 系统地比较可生物吸收与金属螺丝在复杂的脚骨折中的综合性固定的并发症率.
- 评估整体安全性和可靠性生物吸收螺丝固定在骨科创伤.
主要方法:
- 在PubMed和Google Scholar上进行了系统的文献搜索,确定了随机对照试验.
- 包括257名患者在内的四项符合条件的研究被纳入了评估术后并发症率的元分析.
- 为了比较固定方法,计算了风险比率和95%的置信区间.
主要成果:
- 与金属螺丝相比,可生物吸收的螺丝固定与整体并发症的风险显著增加 (RR 3.35,95% CI 1.75-6.42,p = 0.0003).
- 具体的并发症包括更高的修复手术率,感染和生物吸收螺丝的症状硬件问题.
- 在这两种固定方法之间,没有观察到两种固定方法在运动范围结果中的明显优势.
结论:
- 与可生物吸收螺丝相关的高并发症率引起了人们对其在综合性固定中常规使用的担忧.
- 由于生物吸收材料的风险,金属螺丝目前是综合性固定的更可靠和可靠的选择.
- 需要进行未来的研究,以提高可生物吸收材料的生物力学和生物相容性特性,以便在潜在的临床应用中得到应用.
相关概念视频
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


